Vertex Pharmaceuticals other operating income or expenses for the twelve months ending September 30, 2024 were $0.050B, a 10020% decline year-over-year.
Vertex Pharmaceuticals annual other operating income or expenses for 2023 were $0.052B, a 10.26% decline from 2022.
Vertex Pharmaceuticals annual other operating income or expenses for 2022 were $0.058B, a 1754.84% increase from 2021.
Vertex Pharmaceuticals annual other operating income or expenses for 2021 were $0.003B, a 123.66% decline from 2020.
Vertex Pharmaceuticals Other Operating Income or Expenses 2010-2024 | VRTX